Eris Lifesciences Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Eris Lifesciences Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
quick-summary-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

Eris Lifesciences Ltd.

BSE: 540596, NSE: ERIS

  • Market Capitalisation market-capitalisation-info ₹7,809 Cr
  • 12 Month Earnings monthly-earning ₹397 Cr
  • Price to Earnings price-to-earning 19.62

₹574.45

As on 29-Mar-2023 IST

up-down-arrow ₹1.05 • 0.18%

  • Prev Close info

    ₹573.40

  • Day's Openinfo

    ₹573.40

  • Today's Highinfo

    ₹580.75

  • Today's Lowinfo

    ₹570.00

  • Today's Volumeinfo

    2,67,164

Stock Performance
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Eris Lifesciences
-11.25 -9.40 -11.08 -19.06 14.89 -6.40 --
S&P BSE Healthcare
-5.39 -0.05 -5.57 -10.00 23.29 10.62 10.53
S&P BSE Small Cap
-8.05 -2.33 -7.15 -3.81 40.96 9.37 16.44
As on 29-Mar-2023
2022
2021
2020
2019
2018
Eris Lifesciences
-14.84 28.80 16.83 -31.52 -12.34
S&P BSE Small Cap
-1.80 62.77 32.11 -6.85 -23.41
S&P BSE Healthcare
-12.10 20.87 61.45 -3.55 -5.89

Valuation
Stock
Peer Median

Growth & Efficiency
Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

View Details arrow

Peer Comparison

search
search
search
search
    Comparison Details arrow

    Valuation Chart of Eris Lifesciences Ltd.

        Financials

        View Details arrow

        Shareholding Pattern

        View Details arrow

        News & Analysis of Eris Lifesciences Ltd.

        inside-roe

        Inside ROE

        By Jugal Harpalani

        mutual-funds-make-the-most-of-ipos

        Mutual funds make the most of IPOs

        By Kumar Shankar Roy

        All News arrow

        Incorporated

        2007

        Chairman

        Amit Indubhushan Bakshi

        Managing Director

        Amit Indubhushan Bakshi

        Headquarters

        Ahmedabad, Gujarat

        Website

        www.eris.co.in
        More Details arrow
        Edit peer-selector-edit

        Key Facts

        • Market cap market-cap-information ₹7,808.67 Cr
        • Revenue (TTM)revenue-information ₹1,588.30 Cr
        • Earnings (TTM) earning-information ₹397.04 Cr
        • Cash date-information ₹70.08 Cr
        • Total Debt info ₹45.01 Cr
        • Promoters' ownership promoters_ownership 52.70%
        • Liquidity liquidity High
        • 52 Week range week-range ₹551.30 - 749.80
        • Face value face-value ₹1.00
        • Shares outstanding share-outstanding 13,59,92,238
        • 10 Years Aggregate:

          CFO: ₹2,031.81 Cr

          EBITDA: ₹2,698.05 Cr

          Net Profit: ₹2,243.63 Cr

        About The Company

        • Business Manufacture of pharmaceuticals, medicinal chemical and botanical products
        • Incorporated 2007
        • Chairman Amit Indubhushan Bakshi
        • Managing Director Amit Indubhushan Bakshi
        • Listing key-listing BSE: 540596, NSE: ERIS
        • Country India
        • Headquarters headquarters Ahmedabad, Gujarat
        • Website website www.eris.co.in
        Add Portfolio by-stock Add to watchlist watchlist-stock-modal Share Download Stock Report
        Portfolio stock-portfolio Watchlist watchlist-stock-modal share-fund-icon Download Stock Report
        Portfolio stock-investment Watchlist add-watchlist-icon share-fund-plan-icon